Literature DB >> 28642983

[Hebephrenia - a viable psychopathological construct?]

M Jäger1, T Becker2, M E Wigand2.   

Abstract

Ewald Hecker was the first psychiatrist to describe the disease entity of hebephrenia in some detail, focusing mainly on disturbances of affect. Later Emil Kraepelin and Eugen Bleuler saw hebephrenia as a subtype of dementia praecox or schizophrenia. Willy Mayer-Gross and Karl Leonhard characterized hebephrenia with highly differentiated psychopathological descriptions, whereas this construct only played a minor role in the works of Klaus Conrad and Kurt Schneider. The International Classification of Diseases (ICD-10) lists hebephrenia as a subtype of schizophrenia but in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) no subtypes of schizophrenia are mentioned and the concept of hebephrenia is thus lost. Hebephrenia can be seen as an ideal type describing a psychopathological course pattern. This construct can be useful to conceptualize a group of disorders of affect which otherwise escape description, especially since these psychopathological alterations of affect are difficult to operationalize. To have a viable concept of these disorders is relevant for the prognosis and therapy planning. If the concept of hebephrenia is abolished, important psychopathological knowledge might be lost for future generations of psychiatrists.

Entities:  

Keywords:  Course; Diagnosis; Psychopathology; Schizophrenia; Therapy planning

Mesh:

Year:  2018        PMID: 28642983     DOI: 10.1007/s00115-017-0366-3

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  20 in total

1.  The failure of the schizophrenia concept and the argument for its replacement by hebephrenia: applying the medical model for disease recognition.

Authors:  Michael Alan Taylor; Edward Shorter; Nutan Atre Vaidya; Max Fink
Journal:  Acta Psychiatr Scand       Date:  2010-09       Impact factor: 6.392

Review 2.  Revisiting the diagnosis of schizophrenia: where have we been and where are we going?

Authors:  William R Keller; Bernard A Fischer; William T Carpenter
Journal:  CNS Neurosci Ther       Date:  2010-12-27       Impact factor: 5.243

3.  Do patients with paranoid and disorganized schizophrenia respond differently to antipsychotic drugs?

Authors:  C Corves; R R Engel; J Davis; S Leucht
Journal:  Acta Psychiatr Scand       Date:  2013-12-02       Impact factor: 6.392

4.  Impact of DSM-5 changes on the diagnosis and acute treatment of schizophrenia.

Authors:  Taina Mattila; Maarten Koeter; Tamar Wohlfarth; Jitschak Storosum; Wim van den Brink; Lieuwe de Haan; Eske Derks; Hubertus Leufkens; Damiaan Denys
Journal:  Schizophr Bull       Date:  2014-12-20       Impact factor: 9.306

5.  Status of psychotic disorders in ICD-11.

Authors:  Wolfgang Gaebel
Journal:  Schizophr Bull       Date:  2012-09       Impact factor: 9.306

6.  Psychopathological Symptoms Assessed by a System-Specific Approach Are Related to Global Functioning in Schizophrenic Disorders.

Authors:  Fabian U Lang; Annabel S Müller-Stierlin; Sebastian Walther; Thomas G Schulze; Thomas Becker; Markus Jäger
Journal:  Psychopathology       Date:  2016-03-23       Impact factor: 1.944

7.  [The Concept of Typology in Psychiatry in the Context of Historical Contributions of Max Weber and Karl Jaspers].

Authors:  M Jäger; T Becker; M E Wigand
Journal:  Fortschr Neurol Psychiatr       Date:  2016-08-29       Impact factor: 0.752

8.  Psychopathological Course Typology in Schizophrenia Spectrum Disorders: A Heuristic Approach in a Sample of 100 Patients.

Authors:  Moritz E Wigand; Fabian U Lang; Thomas Becker; Thomas G Schulze; Werner Strik; Markus Jäger
Journal:  Psychopathology       Date:  2016-11-09       Impact factor: 1.944

9.  [Autism and autistic disorders. Historical and current aspects].

Authors:  E Kumbier; G Domes; B Herpertz-Dahlmann; S C Herpertz
Journal:  Nervenarzt       Date:  2010-01       Impact factor: 1.214

10.  Toward the future of psychiatric diagnosis: the seven pillars of RDoC.

Authors:  Bruce N Cuthbert; Thomas R Insel
Journal:  BMC Med       Date:  2013-05-14       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.